Evidence map›Paper›PMID 20551513›Full record

ArticleThe Journal of clinical investigation2010

The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice.

Matthew B Greenblatt, Jae-Hyuck Shim, Weiguo Zou, Despina Sitara, Michelle Schweitzer, Dorothy Hu, Sutada Lotinun, Yasuyo Sano, Roland Baron, Jin Mo Park and 7 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 231 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed, 1 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

231 citing papers in PubMed, 1 synthesis or guideline pooled it, 403 citations in OpenAlex.

  1. Beyond the Kidney: A Systematic Review of Extrarenal Manifestations inInternational journal of molecular sciences · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. [Research progress on the role and mechanism of magnesium element and magnesium materials in tendon-bone interface healing].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Multi-system Mechanisms in the Anti-osteoporotic Effects of Herbal Natural Products.Endocrine, metabolic & immune disorders drug targets · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Matthew B GreenblattDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Jae-Hyuck Shim
Weiguo Zou
Despina Sitara
Michelle Schweitzer
Dorothy Hu
Sutada Lotinun
Yasuyo Sano
Roland Baron
Jin Mo Park
Simon Arthur
Min Xie
Michael D Schneider
Bo Zhai
Steven Gygi
Roger Davis
Laurie H Glimcher
Harvard University Press · USImperial College London · GBThe University of Texas Southwestern Medical Center · USUniversity of Dundee · GBUniversity of Massachusetts Chan Medical School · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
TYPE I TGF-BETA RECEPTOR AND CARDIAC MUSCLER01HL052555 · NHLBI · IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE · PI SCHNEIDER, MICHAEL DAVID · 1995 to 2007
$3.6M
Regulatory targets of p38 MAP kinase in inflammationR01AI074957 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI PARK, JIN MO · 2009 to 2013
$1.9M
Novel Regulators of Bone FormationR01HD055601 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI GLIMCHER, LAURIE HOLLIS · 2008 to 2012
$1.4M
Medical Research Council MC_U127081014Medical Research Council U.1270(81014)NHLBI NIH HHS HL52555NHLBI NIH HHS R01 HL052555NIAID NIH HHS R01 AI074957NICHD NIH HHS HD055601NICHD NIH HHS R01 HD055601NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

Nearly every extracellular ligand that has been found to play a role in regulating bone biology acts, at least in part, through MAPK pathways. Nevertheless, much remains to be learned about the contribution of MAPKs to osteoblast biology in vivo. Here we report that the p38 MAPK pathway is required for normal skeletogenesis in mice, as mice with deletion of any of the MAPK pathway member-encoding genes MAPK kinase 3 (Mkk3), Mkk6, p38a, or p38b displayed profoundly reduced bone mass secondary to defective osteoblast differentiation. Among the MAPK kinase kinase (MAP3K) family, we identified TGF-beta-activated kinase 1 (TAK1; also known as MAP3K7) as the critical activator upstream of p38 in osteoblasts. Osteoblast-specific deletion of Tak1 resulted in clavicular hypoplasia and delayed fontanelle fusion, a phenotype similar to the cleidocranial dysplasia observed in humans haploinsufficient for the transcription factor runt-related transcription factor 2 (Runx2). Mechanistic analysis revealed that the TAK1-MKK3/6-p38 MAPK axis phosphorylated Runx2, promoting its association with the coactivator CREB-binding protein (CBP), which was required to regulate osteoblast genetic programs. These findings reveal an in vivo function for p38beta and establish that MAPK signaling is essential for bone formation in vivo. These results also suggest that selective p38beta agonists may represent attractive therapeutic agents to prevent bone loss associated with osteoporosis and aging.

Indexed as

AnimalsCell DifferentiationCREB-Binding ProteinHumansMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMAP Kinase Signaling SystemMiceMice, TransgenicMitogen-Activated Protein Kinase 14Mitogen-Activated Protein Kinase KinasesOsteoblastsOsteogenesisp38 Mitogen-Activated Protein KinasesPhosphorylationProto-Oncogene ProteinsCREB-Binding ProteinCREBBP protein, humanMAP3K8 protein, humanMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMitogen-Activated Protein Kinase 14Mitogen-Activated Protein Kinase Kinasesp38 Mitogen-Activated Protein KinasesProto-Oncogene ProteinsTransforming Growth Factor beta

Identifiers

PMID20551513
PMCPMC2898605
OpenAlexW2106247097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.